Cell Culture Market

Report Code BT 2561
Published in Mar, 2024, By MarketsandMarkets™
Download PDF

Choose License Type

Buy Report Now Inquire Before Buying

Cell Culture Market by Product (Consumables (Media, Sera, Reagents), Vessels (Roller Bottle, Cell Factory, Flask), Equipment (SU Bioreactor, Storage, Incubators, Filtration)), Application (mAbs, Vaccines, Regenerative Medicine) & Region - Global Forecast to 2029

Overview

The global X-Ray Detectors market in terms of revenue was estimated to be worth $3.1 billion in 2023 and is poised to reach $4.2 billion by 2029, growing at a CAGR of 5.0% from 2023 to 2029. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The rising prevalence of cardiac arrests in the United States and worldwide has led to a higher mortality rate. However, advancements in imaging systems and products are playing a crucial role in cardiac imaging, facilitating early disease detection. These developments are not only improving the diagnostic and prognostic capabilities of healthcare professionals but also enabling them to better support patients dealing with issues such as tumors, orthopedic pains, and veterinary care.

Attractive Opportunities in the Cell Culture Market

ASIA PACIFIC

The Asia Pacific market is witnessing revenue growth attributed to heightened demand for minimally invasive procedures, a firmly established healthcare sector, the expanding clinical applications of X-ray detectors, and an increasing need for early diagnosis.

Key companies' intensified research and development endeavors have led to the creation and introduction of cutting-edge products.

Strong growth opportunities exist in emerging markets like China, Brazil, and India within this market. The creation of home-use devices is also a notable area of opportunity.

The predominant share of X-ray detectors is held by North America, primarily attributed to the extensive utilization of minimally invasive procedures, an expanding geriatric population, increasing awareness, and favorable government funding for healthcare infrastructure in this region.

Ranking as the second-largest market for X-Ray detectors, Asia Pacific is experiencing notable growth. The substantial potential of X-ray detectors in the early detection of diverse diseases and the elevated adoption rate are contributing to the rapid expansion of the Asian market.

Global Cell Culture Market Dynamics

DRIVER: Investment to advance healthcare facilities & digital imaging Technologies.

X-Ray detectors play a crucial role in facilitating the work of healthcare professionals in diagnosing and treating patients. The efficient utilization of cutting-edge equipment, like X-ray detectors, enables the screening of a greater number of patients at reduced expenses and with significant time savings. Increased support, funding, and investments are expected to substantially enhance the accessibility and adoption of these technologies, contributing to the continued growth of the market.

RESTRAINT: High cost of X-ray detectors

The X-ray detector market faces limitations due to the high cost associated with these devices. Beyond being a constraint, this factor poses a challenge for economically disadvantaged and developing nations seeking to embrace new technologies. Insufficient funding in many hospitals further hinders the possibility of acquiring these modern technologies. As countries globally aim to advance and integrate state-of-the-art technologies, manual security checks are becoming obsolete. However, the concern of health hazards arises, particularly in security applications, as these detectors have demonstrated a potential link to cancer, presenting a genuine limitation. Additionally, addressing the shortage of qualified radiologists is another pressing issue that needs attention.

 

OPPORTUNITY: Rising healthcare expenditure across developing countries

Within the X-ray detector market, there are promising opportunities in emerging regions like the Asia-Pacific (APAC) and India. These countries are experiencing substantial growth in medical tourism, fueled by factors such as population expansion, increasing sedentary lifestyles, and the rapid development of medical tourism infrastructure. These elements are driving an uptick in health issues like cardiovascular and neurovascular diseases. Furthermore, these nations boast above-average returns on investments and are recognized for having a skilled labor force. Government initiatives and policies are actively fostering the development and expansion of the medical tourism industries in these countries.

CHALLENGE: Lack of animal awareness in emerging and developing countries

The X-ray detector market faces ongoing challenges from global competitors, with Chinese players holding significant influence. Moreover, the expenditure on animal health in developing nations, such as India, China, and Africa, is notably limited when compared to industrialized countries like North America. Additionally, these growing nations lack a well-established understanding of animal health, prioritizing therapeutic medical treatments over procedures involving X-ray detectors.

Global Cell Culture Market Ecosystem Analysis

 

 

By application, the medical application market will register significant growth in the x-ray detectors industry near future.

Based on application, the x-ray detectors market is segmented into medical applications, dental applications, security/defense applications, veterinary applications, industrial application, and other applications. The medical applications segment market by application registers the highest growth rate during the forecast period. The main factors fueling the highest growth rate in this segment can be attributed to the expanding target patient population.

By technology, the flat-panel detectors segment accounted for the largest share in the x-ray detectors industry 2024.

Based on technology, the x-ray detectors market is segmented into flat-panel detectors, computed radiography detectors, line-scan detectors, and charge-coupled device detectors system. in 2024, the flat-panel detectors segment accounted for the largest market share. The growth of the X-ray detectors market is propelled by the increasing adoption of advanced instruments that enhance precise diagnostics and the growing demand for improved sensitivity in this specific segment.

NORTH AMERICA region holds the largest share of the Cell Culture Market.

North America, comprising the US and Canada, accounted for the largest share of the X-ray detectors market in 2022. The growth of the X-ray detector market in North America is propelled by several factors, including the rising number of target diagnostic and interventional procedures conducted in the region, a high prevalence of diseases, an increasing geriatric population, and the widespread availability of advanced interventional products, including microcatheters.

 
 

Recent Developments of Cell Culture Market industry

  • In May 2023, Varex Imaging Corporation launched the XRD 3131N digital X-ray detector to cater to the rising demand for expedited and more extensive inspections within the rapidly evolving Electric Vehicle (EV) battery manufacturing sector. This enhances the company's existing portfolio for the EV battery inspection market. In July 2022, Canon Inc. launched the CXDI-Elite series of wireless digital radiography (DR2) devices, including the CXDI-720C Wireless sensor unit, to markets outside of Japan. These devices aim to enhance user-friendliness across various imaging scenarios while delivering superior image quality to facilitate more accurate diagnostics.
  • March 2021, At ECF 2021, the Thales unveiled the Pixium 3040F, featuring enhanced image quality, optimized spatial resolution, increased contrast, and superior sensitivity at lower radiation doses.

Key Market Players

Want to explore hidden markets that can drive new revenue in Cell Culture Market?

Scope of the Report

Report Attribute Details
Market Revenue in 2023 $3.1 billion
Projected Revenue by 2029 $4.2 billion
Revenue Rate Poised to Grow at a CAGR of 5.0%
Market Driver Investment to advance healthcare facilities & digital imaging Technologies.
Market Opportunity Rising healthcare expenditure across developing countries

 

Key Questions Addressed by the Report

What is the projected market revenue value of the global X-Ray Detectors Market?
The global X-Ray Detectors market boasts a total revenue value of $4.2 billion by 2029.
What is the estimated growth rate (CAGR) of the global X-Ray Detectors Market?
The market has an estimated CAGR of 5.0%, with a revenue size of $3.1 billion in 2023.

 

Personalize This Research

  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
Request A Free Customisation

Let Us Help You

  • What are the Known and Unknown Adjacencies Impacting the Cell Culture Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
Customized Workshop Request

Table of Contents

Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE
PAGE NO
INTRODUCTION
53
RESEARCH METHODOLOGY
60
EXECUTIVE SUMMARY
75
PREMIUM INSIGHTS
78
MARKET OVERVIEW
81
  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    DRIVERS
    - Increasing support and funding from government and private organizations for cell-based research
    - Emerging cell culture technologies for production of cell-based viral vaccines
    - Growing popularity of monoclonal antibodies and biosimilars
    - Adoption of single-use technologies
    - Growing focus of key players on product launches
    - Growth in advanced therapy medicinal products
    - Increasing incidence of infectious diseases
    RESTRAINTS
    - High cost of cell biology research
    - Limitations in producing high-density cell cultures
    OPPORTUNITIES
    - Rising demand for 3D cell cultures
    - Emerging economies offer lucrative growth opportunities
    - Increasing focus on next-generation therapeutics
    CHALLENGES
    - Disposal of plastic consumables
    - Ethical concerns related to cell usage
  • 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
  • 5.4 PRICING ANALYSIS
    AVERAGE SELLING PRICE OF CELL CULTURE EQUIPMENT AND CONSUMABLES
    AVERAGE SELLING PRICE OF CELL CULTURE PRODUCTS, BY REGION
  • 5.5 TECHNOLOGY ANALYSIS
    KEY TECHNOLOGIES
    - Single-use technology
    - Flow cytometry
    - Microscopy
    COMPLEMENTARY TECHNOLOGIES
    - High-throughput screening
    - Mass spectrometry
    ADJACENT TECHNOLOGIES
    - Microfluidics and organ-on-a-chip
    - 3D bioprinting
  • 5.6 TRADE DATA
  • 5.7 PATENT ANALYSIS
    METHODOLOGY
    PATENTS FILED, BY DOCUMENT TYPE, 2014–2024
    INNOVATION AND PATENT APPLICATIONS
    TOP APPLICANTS
  • 5.8 VALUE CHAIN ANALYSIS
  • 5.9 SUPPLY CHAIN ANALYSIS
  • 5.10 ECOSYSTEM ANALYSIS
    CELL CULTURE MARKET: ROLE OF RAW MATERIAL VENDORS
    CELL CULTURE MARKET: ROLE OF PRODUCT PROVIDERS
    CELL CULTURE MARKET: ROLE OF END USERS
    CELL CULTURE MARKET: ROLE OF REGULATORY AUTHORITIES
  • 5.11 PORTER’S FIVE FORCES ANALYSIS
    THREAT OF NEW ENTRANTS
    THREAT OF SUBSTITUTES
    BARGAINING POWER OF SUPPLIERS
    BARGAINING POWER OF BUYERS
    INTENSITY OF COMPETITIVE RIVALRY
  • 5.12 REGULATORY LANDSCAPE
    REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    REGULATORY SCENARIO
  • 5.13 KEY CONFERENCES & EVENTS, 2024–2025
  • 5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
    KEY STAKEHOLDERS IN BUYING PROCESS
    BUYING CRITERIA FOR CELL CULTURE
  • 5.15 INVESTMENT AND FUNDING SCENARIO
CELL CULTURE MARKET, BY PRODUCT
141
  • 6.1 INTRODUCTION
  • 6.2 CONSUMABLES
    SERA, MEDIA, AND REAGENTS
    - Media
    - Reagents
    - Sera
    VESSELS
    - Cell factory systems/cell stacks
    - Roller/roux bottles
    - Flasks
    - Multiwell plates
    - Petri dishes
    ACCESSORIES
    - Reduced preparation time and equipment performance improvements to drive market
  • 6.3 EQUIPMENT
    BIOREACTORS
    - Conventional bioreactors
    - Single-use bioreactors
    STORAGE EQUIPMENT
    - Refrigerators & freezers
    - Cryostorage systems
    OTHER EQUIPMENT
    - Filtration systems
    - Cell counters
    - Carbon dioxide incubators
    - Centrifuges
    - Autoclaves
    - Microscopes
    - Biosafety cabinets
    - Other supporting equipment
CELL CULTURE MARKET, BY APPLICATION
312
  • 7.1 INTRODUCTION
  • 7.2 BIOPHARMACEUTICAL PRODUCTION
    MONOCLONAL ANTIBODY PRODUCTION
    - Increasing approval and launch of mAb candidates to drive growth
    VACCINE PRODUCTION
    - Rising incidence of infectious diseases to support market growth
    OTHER THERAPEUTIC PROTEIN PRODUCTION
  • 7.3 DIAGNOSTICS
    ADVANCEMENTS AND ADOPTION OF NEW TECHNIQUES TO DRIVE SEGMENT GROWTH
  • 7.4 TISSUE ENGINEERING & REGENERATIVE MEDICINE
    CELL & GENE THERAPY
    - New product launches and strategic alliances to drive segment growth
    OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS
  • 7.5 DRUG SCREENING & DEVELOPMENT
    INCREASING NEW DRUG DEVELOPMENT ACTIVITIES TO DRIVE MARKET
  • 7.6 OTHER APPLICATIONS
CELL CULTURE MARKET, BY END USER
351
  • 8.1 INTRODUCTION
  • 8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES TO HOLD LARGEST MARKET SHARE DURING FORECAST PERIOD
  • 8.3 HOSPITALS & DIAGNOSTIC LABORATORIES
    INCREASING DEMAND FOR CELL CULTURE PRODUCTS AND STRATEGIC ACTIVITIES TO DRIVE SEGMENT
  • 8.4 RESEARCH & ACADEMIC INSTITUTES
    INCREASING FUNDING ACTIVITIES TO DRIVE MARKET
  • 8.5 OTHER END USERS
CELL CULTURE MARKET, BY REGION
368
  • 9.1 INTRODUCTION
  • 9.2 NORTH AMERICA
    NORTH AMERICA: RECESSION IMPACT
    US
    - US to hold largest share of North American market
    CANADA
    - Increasing funding and investments for advancing cell-based therapies to boost market
  • 9.3 EUROPE
    EUROPE: RECESSION IMPACT
    GERMANY
    - Rising R&D investments and strategic alliances to drive market
    UK
    - Growth in life science industry and favorable government investments to support market
    FRANCE
    - Rising number of cell-based research projects to enhance market growth
    ITALY
    - Strong government support to enhance R&D activities
    SPAIN
    - Booming biotechnology industry to aid market growth
    REST OF EUROPE
  • 9.4 ASIA PACIFIC
    ASIA PACIFIC: RECESSION IMPACT
    CHINA
    - China to register highest growth rate in Asia Pacific market
    JAPAN
    - Rising government initiatives and increasing investments in biotech to drive market
    INDIA
    - Favorable government support and expansion by key cell culture players to augment market growth
    SOUTH KOREA
    - Growing pharmaceutical sector to drive market
    AUSTRALIA
    - Increasing prevalence of chronic diseases to drive market
    REST OF ASIA PACIFIC
  • 9.5 LATIN AMERICA
    LATIN AMERICA: RECESSION IMPACT
    BRAZIL
    - Rising prevalence of cancer and related research activities to support market growth
    MEXICO
    - Growth in biopharmaceutical market to spur cell culture demand
    REST OF LATIN AMERICA
  • 9.6 MIDDLE EAST
    MIDDLE EAST: RECESSION IMPACT
    GCC COUNTRIES
    - Saudi Arabia
    - UAE
    - Rest of GCC Countries
    REST OF MIDDLE EAST
  • 9.7 AFRICA
    RISING GRANTS AND FUNDING FOR CELL AND GENE THERAPY PRODUCTS TO FUEL MARKET GROWTH
    AFRICA: RECESSION IMPACT
COMPETITIVE LANDSCAPE
570
  • 10.1 INTRODUCTION
  • 10.2 STRATEGIES ADOPTED BY KEY PLAYERS
  • 10.3 REVENUE SHARE ANALYSIS
  • 10.4 MARKET SHARE ANALYSIS
  • 10.5 BRAND/PRODUCT COMPARATIVE ANALYSIS
    THERMO FISHER SCIENTIFIC INC.
    DANAHER CORPORATION
    MERCK KGAA
    SARTORIUS AG
    CORNING INCORPORATED
  • 10.6 COMPANY EVALUATION MATRIX: KEY PLAYERS
    STARS
    EMERGING LEADERS
    PERVASIVE PLAYERS
    PARTICIPANTS
    COMPANY FOOTPRINT: KEY PLAYERS
  • 10.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES
    PROGRESSIVE COMPANIES
    RESPONSIVE COMPANIES
    DYNAMIC COMPANIES
    STARTING BLOCKS
    COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • 10.8 VALUATION AND FINANCIAL METRICS OF CELL CULTURE VENDORS
  • 10.9 COMPETITIVE SCENARIO
    PRODUCT LAUNCHES
    DEALS
    EXPANSIONS
COMPANY PROFILES
593
  • 11.1 INTRODUCTION
  • 11.2 KEY PLAYERS
    THERMO FISHER SCIENTIFIC INC.
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    DANAHER CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    MERCK KGAA
    - Business overview
    - Products offered
    - Recent developments
    - MnM view
    SARTORIUS AG
    - Business overview
    - Products offered
    - Recent developments
    CORNING INCORPORATED
    - Business overview
    - Products offered
    - Recent developments
    FUJIFILM HOLDINGS CORPORATION
    - Business overview
    - Products offered
    - Recent developments
    BD
    - Business overview
    - Product offered
    - Recent developments
    EPPENDORF SE
    - Business overview
    - Products offered
    - Recent developments
    LONZA
    - Business overview
    - Products offered
    - Recent developments
    GETINGE AB
    - Business overview
    - Products offered
    - Recent developments
    AGILENT TECHNOLOGIES, INC.
    - Business overview
    - Products offered
    - Recent developments
    HIMEDIA LABORATORIES
    - Business overview
    - Products offered
    BIO-TECHNE
    - Business overview
    - Products offered
    - Recent developments
  • 11.3 OTHER PLAYERS
    MILTENYI BIOTEC
    STEMCELL TECHNOLOGIES
    SOLIDA BIOTECH GMBH
    CAISSON LABS INC.
    PROMOCELL GMBH
    INVIVOGEN
    PAN-BIOTECH
    CELLEXUS
    MEISSNER FILTRATION PRODUCTS, INC.
    ADOLF KÜHNER AG
    ADVANCION CORPORATION
    BIOSPHERIX, LTD.
APPENDIX
729
  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS
LIST OF TABLES
 
  • TABLE 1 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS
  • TABLE 2 CELL CULTURE MARKET: IMPACT ANALYSIS
  • TABLE 3 NIH FUNDING FOR STEM CELL-BASED RESEARCH, 2020–2024 (USD MILLION)
  • TABLE 4 FUNDING INVESTMENTS IN CELL & GENE THERAPY
  • TABLE 5 COMMERCIALLY SPONSORED MONOCLONAL ANTIBODY THERAPEUTICS GRANTED FIRST APPROVAL IN 2023
  • TABLE 6 ASIA PACIFIC PRIVATE ROUNDS IN BIOTECH COMPANIES FOCUSED ON HEALTHCARE, 2023
  • TABLE 7 COMPARISON OF SINGLE-USE BIOPROCESSING SYSTEM DISPOSAL OPTIONS
  • TABLE 8 AVERAGE SELLING PRICE RANGE OF CELL CULTURE EQUIPMENT AND CONSUMABLES, BY KEY PLAYER
  • TABLE 9 AVERAGE SELLING PRICE RANGE OF SINGLE-USE ASSEMBLIES, BY REGION
  • TABLE 10 AVERAGE SELLING PRICE OF DIFFERENT TYPES OF MEDIA/1000L IN DEVELOPED AND DEVELOPING COUNTRIES (2023)
  • TABLE 11 ADVANTAGES OF SINGLE-USE AND STAINLESS-STEEL BIOREACTORS
  • TABLE 12 ADVANTAGES AND DISADVANTAGES OF MICROFLUIDIC CELL CULTURE
  • TABLE 13 IMPORT VALUE FOR CELL CULTURE MEDIA, 2018–2022 (USD THOUSAND)
  • TABLE 14 EXPORT VALUE FOR CELL CULTURE MEDIA, 2018–2022 (USD THOUSAND)
  • TABLE 15 IMPORT VOLUME FOR CELL CULTURE MEDIA, 2018–2022 (TONS)
  • TABLE 16 EXPORT VOLUME FOR CELL CULTURE MEDIA, 2018–2022 (TONS)
  • TABLE 17 PATENTS FILED, 2014–2024
  • TABLE 18 TOP 20 PATENT OWNERS IN CELL CULTURE, 2014–2024
  • TABLE 19 INDICATIVE LIST OF PATENTS IN CELL CULTURE MARKET, 2022–2024
  • TABLE 20 CELL CULTURE MARKET: ROLE OF RAW MATERIAL VENDORS
  • TABLE 21 CELL CULTURE MARKET: ROLE OF PRODUCT PROVIDERS
  • TABLE 22 CELL CULTURE MARKET: ROLE OF END USERS
  • TABLE 23 CELL CULTURE MARKET: ROLE OF REGULATORY AUTHORITIES
  • TABLE 24 CELL CULTURE MARKET: PORTER’S FIVE FORCES ANALYSIS
  • TABLE 25 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 26 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 27 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 28 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 29 CELL CULTURE MARKET: REGULATORY GUIDELINES
  • TABLE 30 CELL CULTURE MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2024–2025
  • TABLE 31 BUYING CRITERIA FOR CELL CULTURE PRODUCTS, BY END USER
  • TABLE 32 CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 33 CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 34 CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 35 NORTH AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 36 EUROPE: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 37 ASIA PACIFIC: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 38 LATIN AMERICA: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 39 MIDDLE EAST: CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 40 GCC COUNTRIES: CONSUMABLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 41 SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 42 SERA, MEDIA, AND REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 43 NORTH AMERICA: SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 44 EUROPE: SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 45 ASIA PACIFIC: SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 46 LATIN AMERICA: SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 47 MIDDLE EAST: SERA, MEDIA, AND REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 48 GCC COUNTRIES: SERA, MEDIA, AND REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 49 MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 50 MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 51 MEDIA MARKET, BY REGION, 2022-2029 (MILLION LITERS)
  • TABLE 52 NORTH AMERICA: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 53 EUROPE: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 54 ASIA PACIFIC: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 55 LATIN AMERICA: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 56 MIDDLE EAST: MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 57 GCC COUNTRIES: MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 58 SERUM-FREE MEDIA OFFERED BY KEY MARKET PLAYERS
  • TABLE 59 SERUM-FREE MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 60 NORTH AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 61 EUROPE: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 62 ASIA PACIFIC: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 63 LATIN AMERICA: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 64 MIDDLE EAST: SERUM-FREE MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 65 GCC COUNTRIES: SERUM-FREE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 66 CLASSICAL MEDIA & SALTS OFFERED BY KEY MARKET PLAYERS
  • TABLE 67 CLASSICAL MEDIA & SALTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 68 NORTH AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 69 EUROPE: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 70 ASIA PACIFIC: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 71 LATIN AMERICA: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 72 MIDDLE EAST: CLASSICAL MEDIA & SALTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 73 GCC COUNTRIES: CLASSICAL MEDIA & SALTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 74 STEM CELL CULTURE MEDIA OFFERED BY KEY MARKET PLAYERS
  • TABLE 75 STEM CELL CULTURE MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 76 NORTH AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 77 EUROPE: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 78 ASIA PACIFIC: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 79 LATIN AMERICA: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 80 MIDDLE EAST: STEM CELL CULTURE MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 81 GCC COUNTRIES: STEM CELL CULTURE MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 82 CHEMICALLY DEFINED MEDIA OFFERED BY KEY MARKET PLAYERS
  • TABLE 83 CHEMICALLY DEFINED MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 84 NORTH AMERICA: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 85 EUROPE: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 86 ASIA PACIFIC: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 87 LATIN AMERICA: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 88 MIDDLE EAST: CHEMICALLY DEFINED MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 89 GCC COUNTRIES: CHEMICALLY DEFINED MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 90 SPECIALTY MEDIA OFFERED BY KEY MARKET PLAYERS
  • TABLE 91 SPECIALTY MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 92 NORTH AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 93 EUROPE: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 94 ASIA PACIFIC: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 95 LATIN AMERICA: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 96 MIDDLE EAST: SPECIALTY MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 97 GCC COUNTRIES: SPECIALTY MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 98 OTHER MEDIA OFFERED BY KEY MARKET PLAYERS
  • TABLE 99 OTHER MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 100 NORTH AMERICA: OTHER MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 101 EUROPE: OTHER MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 102 ASIA PACIFIC: OTHER MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 103 LATIN AMERICA: OTHER MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 104 MIDDLE EAST: OTHER MEDIA MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 105 GCC COUNTRIES: OTHER MEDIA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 106 REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 107 REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 108 NORTH AMERICA: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 109 EUROPE: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 110 ASIA PACIFIC: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 111 LATIN AMERICA: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 112 MIDDLE EAST: REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 113 GCC COUNTRIES: REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 114 GROWTH FACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 115 NORTH AMERICA: GROWTH FACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 116 EUROPE: GROWTH FACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 117 ASIA PACIFIC: GROWTH FACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 118 LATIN AMERICA: GROWTH FACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 119 MIDDLE EAST: GROWTH FACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 120 GCC COUNTRIES: GROWTH FACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 121 SUPPLEMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 122 NORTH AMERICA: SUPPLEMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 123 EUROPE: SUPPLEMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 124 ASIA PACIFIC: SUPPLEMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 125 LATIN AMERICA: SUPPLEMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 126 MIDDLE EAST: SUPPLEMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 127 GCC COUNTRIES: SUPPLEMENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 128 BUFFERS & CHEMICALS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 129 NORTH AMERICA: BUFFERS & CHEMICALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 130 EUROPE: BUFFERS & CHEMICALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 131 ASIA PACIFIC: BUFFERS & CHEMICALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 132 LATIN AMERICA: BUFFERS & CHEMICALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 133 MIDDLE EAST: BUFFERS & CHEMICALS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 134 GCC COUNTRIES: BUFFERS & CHEMICALS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 135 CELL DISSOCIATION REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 136 NORTH AMERICA: CELL DISSOCIATION REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 137 EUROPE: CELL DISSOCIATION REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 138 ASIA PACIFIC: CELL DISSOCIATION REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 139 LATIN AMERICA: CELL DISSOCIATION REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 140 MIDDLE EAST: CELL DISSOCIATION REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 141 GCC COUNTRIES: CELL DISSOCIATION REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 142 BALANCED SALT SOLUTIONS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 143 NORTH AMERICA: BALANCED SALT SOLUTIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 144 EUROPE: BALANCED SALT SOLUTIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 145 ASIA PACIFIC: BALANCED SALT SOLUTIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 146 LATIN AMERICA: BALANCED SALT SOLUTIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 147 MIDDLE EAST: BALANCED SALT SOLUTIONS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 148 GCC COUNTRIES: BALANCED SALT SOLUTIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 149 ATTACHMENT & MATRIX FACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 150 NORTH AMERICA: ATTACHMENT & MATRIX FACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 151 EUROPE: ATTACHMENT & MATRIX FACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 152 ASIA PACIFIC: ATTACHMENT & MATRIX FACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 153 LATIN AMERICA: ATTACHMENT & MATRIX FACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 154 MIDDLE EAST: ATTACHMENT & MATRIX FACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 155 GCC COUNTRIES: ATTACHMENT & MATRIX FACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 156 ANTIBIOTICS/ANTIMYCOTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 157 NORTH AMERICA: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 158 EUROPE: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 159 ASIA PACIFIC: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 160 LATIN AMERICA: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 161 MIDDLE EAST: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 162 GCC COUNTRIES: ANTIBIOTICS/ANTIMYCOTICS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 163 CRYOPROTECTIVE REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 164 NORTH AMERICA: CRYOPROTECTIVE REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 165 EUROPE: CRYOPROTECTIVE REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 166 ASIA PACIFIC: CRYOPROTECTIVE REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 167 LATIN AMERICA: CRYOPROTECTIVE REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 168 MIDDLE EAST: CRYOPROTECTIVE REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 169 GCC COUNTRIES: CRYOPROTECTIVE REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 170 CONTAMINATION DETECTION KITS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 171 NORTH AMERICA: CONTAMINATION DETECTION KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 172 EUROPE: CONTAMINATION DETECTION KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 173 ASIA PACIFIC: CONTAMINATION DETECTION KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 174 LATIN AMERICA: CONTAMINATION DETECTION KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 175 MIDDLE EAST: CONTAMINATION DETECTION KITS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 176 GCC COUNTRIES: CONTAMINATION DETECTION KITS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 177 OTHER REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 178 NORTH AMERICA: OTHER REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 179 EUROPE: OTHER REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 180 ASIA PACIFIC: OTHER REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 181 LATIN AMERICA: OTHER REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 182 MIDDLE EAST: OTHER REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 183 GCC COUNTRIES: OTHER REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 184 SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 185 SERA MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 186 NORTH AMERICA: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 187 EUROPE: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 188 ASIA PACIFIC: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 189 LATIN AMERICA: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 190 MIDDLE EAST: SERA MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 191 GCC COUNTRIES: SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 192 FETAL BOVINE SERA MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 193 NORTH AMERICA: FETAL BOVINE SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 194 EUROPE: FETAL BOVINE SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 195 ASIA PACIFIC: FETAL BOVINE SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 196 LATIN AMERICA: FETAL BOVINE SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 197 MIDDLE EAST: FETAL BOVINE SERA MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 198 GCC COUNTRIES: FETAL BOVINE SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 199 ADULT BOVINE SERA MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 200 NORTH AMERICA: ADULT BOVINE SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 201 EUROPE: ADULT BOVINE SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 202 ASIA PACIFIC: ADULT BOVINE SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 203 LATIN AMERICA: ADULT BOVINE SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 204 MIDDLE EAST: ADULT BOVINE SERA MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 205 GCC COUNTRIES: ADULT BOVINE SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 206 OTHER ANIMAL SERA MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 207 NORTH AMERICA: OTHER ANIMAL SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 208 EUROPE: OTHER ANIMAL SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 209 ASIA PACIFIC: OTHER ANIMAL SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 210 LATIN AMERICA: OTHER ANIMAL SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 211 MIDDLE EAST: OTHER ANIMAL SERA MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 212 GCC COUNTRIES: OTHER ANIMAL SERA MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 213 VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 214 VESSELS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 215 NORTH AMERICA: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 216 EUROPE: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 217 ASIA PACIFIC: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 218 LATIN AMERICA: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 219 MIDDLE EAST: VESSELS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 220 GCC COUNTRIES: VESSELS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 221 CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 222 NORTH AMERICA: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 223 EUROPE: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 224 ASIA PACIFIC: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 225 LATIN AMERICA: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 226 MIDDLE EAST: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 227 GCC COUNTRIES: CELL FACTORY SYSTEMS/CELL STACKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 228 ROLLER/ROUX BOTTLES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 229 NORTH AMERICA: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 230 EUROPE: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 231 ASIA PACIFIC: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 232 LATIN AMERICA: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 233 MIDDLE EAST: ROLLER/ROUX BOTTLES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 234 GCC COUNTRIES: ROLLER/ROUX BOTTLES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 235 FLASKS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 236 NORTH AMERICA: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 237 EUROPE: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 238 ASIA PACIFIC: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 239 LATIN AMERICA: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 240 MIDDLE EAST: FLASKS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 241 GCC COUNTRIES: FLASKS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 242 MULTIWELL PLATES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 243 NORTH AMERICA: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 244 EUROPE: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 245 ASIA PACIFIC: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 246 LATIN AMERICA: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 247 MIDDLE EAST: MULTIWELL PLATES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 248 GCC COUNTRIES: MULTIWELL PLATES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 249 PETRI DISHES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 250 NORTH AMERICA: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 251 EUROPE: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 252 ASIA PACIFIC: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 253 LATIN AMERICA: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 254 MIDDLE EAST: PETRI DISHES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 255 GCC COUNTRIES: PETRI DISHES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 256 ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 257 NORTH AMERICA: ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 258 EUROPE: ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 259 ASIA PACIFIC: ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 260 LATIN AMERICA: ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 261 MIDDLE EAST: ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 262 GCC COUNTRIES: ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 263 EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 264 EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 265 NORTH AMERICA: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 266 EUROPE: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 267 ASIA PACIFIC: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 268 LATIN AMERICA: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 269 MIDDLE EAST: EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 270 GCC COUNTRIES: EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 271 BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 272 BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 273 NORTH AMERICA: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 274 EUROPE: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 275 ASIA PACIFIC: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 276 LATIN AMERICA: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 277 MIDDLE EAST: BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 278 GCC COUNTRIES: BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 279 CONVENTIONAL BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 280 NORTH AMERICA: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 281 EUROPE: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 282 ASIA PACIFIC: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 283 LATIN AMERICA: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 284 MIDDLE EAST: CONVENTIONAL BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 285 GCC COUNTRIES: CONVENTIONAL BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 286 LIST OF COMMERCIALLY AVAILABLE SINGLE-USE BIOREACTORS, BY KEY PLAYER
  • TABLE 287 SINGLE-USE BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 288 NORTH AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 289 EUROPE: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 290 ASIA PACIFIC: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 291 LATIN AMERICA: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 292 MIDDLE EAST: SINGLE-USE BIOREACTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 293 GCC COUNTRIES: SINGLE-USE BIOREACTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 294 STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 295 STORAGE EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 296 NORTH AMERICA: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 297 EUROPE: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 298 ASIA PACIFIC: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 299 LATIN AMERICA: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 300 MIDDLE EAST: STORAGE EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 301 GCC COUNTRIES: STORAGE EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 302 REFRIGERATORS & FREEZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 303 NORTH AMERICA: REFRIGERATORS & FREEZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 304 EUROPE: REFRIGERATORS & FREEZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 305 ASIA PACIFIC: REFRIGERATORS & FREEZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 306 LATIN AMERICA: REFRIGERATORS & FREEZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 307 MIDDLE EAST: REFRIGERATORS & FREEZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 308 GCC COUNTRIES: REFRIGERATORS & FREEZERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 309 CRYOSTORAGE SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 310 NORTH AMERICA: CRYOSTORAGE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 311 EUROPE: CRYOSTORAGE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 312 ASIA PACIFIC: CRYOSTORAGE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 313 LATIN AMERICA: CRYOSTORAGE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 314 MIDDLE EAST: CRYOSTORAGE SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 315 GCC COUNTRIES: CRYOSTORAGE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 316 OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 317 OTHER EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 318 NORTH AMERICA: OTHER EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 319 EUROPE: OTHER EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 320 ASIA PACIFIC: OTHER EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 321 LATIN AMERICA: OTHER EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 322 MIDDLE EAST: OTHER EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 323 GCC COUNTRIES: OTHER EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 324 LIST OF FILTRATION SYSTEMS, BY KEY PLAYER
  • TABLE 325 FILTRATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 326 NORTH AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 327 EUROPE: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 328 ASIA PACIFIC: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 329 LATIN AMERICA: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 330 MIDDLE EAST: FILTRATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 331 GCC COUNTRIES: FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 332 LIST OF COMMERCIALLY AVAILABLE CELL COUNTERS, BY KEY PLAYER
  • TABLE 333 CELL COUNTERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 334 NORTH AMERICA: CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 335 EUROPE: CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 336 ASIA PACIFIC: CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 337 LATIN AMERICA: CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 338 MIDDLE EAST: CELL COUNTERS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 339 GCC COUNTRIES: CELL COUNTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 340 CARBON DIOXIDE INCUBATORS OFFERED BY KEY MARKET PLAYERS
  • TABLE 341 CARBON DIOXIDE INCUBATORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 342 NORTH AMERICA: CARBON DIOXIDE INCUBATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 343 EUROPE: CARBON DIOXIDE INCUBATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 344 ASIA PACIFIC: CARBON DIOXIDE INCUBATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 345 LATIN AMERICA: CARBON DIOXIDE INCUBATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 346 MIDDLE EAST: CARBON DIOXIDE INCUBATORS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 347 GCC COUNTRIES: CARBON DIOXIDE INCUBATORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 348 CENTRIFUGES OFFERED BY KEY MARKET PLAYERS
  • TABLE 349 CENTRIFUGES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 350 NORTH AMERICA: CENTRIFUGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 351 EUROPE: CENTRIFUGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 352 ASIA PACIFIC: CENTRIFUGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 353 LATIN AMERICA: CENTRIFUGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 354 MIDDLE EAST: CENTRIFUGES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 355 GCC COUNTRIES: CENTRIFUGES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 356 AUTOCLAVES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 357 NORTH AMERICA: AUTOCLAVES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 358 EUROPE: AUTOCLAVES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 359 ASIA PACIFIC: AUTOCLAVES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 360 LATIN AMERICA: AUTOCLAVES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 361 MIDDLE EAST: AUTOCLAVES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 362 GCC COUNTRIES: AUTOCLAVES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 363 MICROSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 364 NORTH AMERICA: MICROSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 365 EUROPE: MICROSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 366 ASIA PACIFIC: MICROSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 367 LATIN AMERICA: MICROSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 368 MIDDLE EAST: MICROSCOPES MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 369 GCC COUNTRIES: MICROSCOPES MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 370 BIOSAFETY CABINETS OFFERED BY KEY MARKET PLAYERS
  • TABLE 371 BIOSAFETY CABINETS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 372 NORTH AMERICA: BIOSAFETY CABINETS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 373 EUROPE: BIOSAFETY CABINETS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 374 ASIA PACIFIC: BIOSAFETY CABINETS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 375 LATIN AMERICA: BIOSAFETY CABINETS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 376 MIDDLE EAST: BIOSAFETY CABINETS MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 377 GCC COUNTRIES: BIOSAFETY CABINETS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 378 OTHER SUPPORTING EQUIPMENT OFFERED BY KEY MARKET PLAYERS
  • TABLE 379 OTHER SUPPORTING EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 380 NORTH AMERICA: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 381 EUROPE: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 382 ASIA PACIFIC: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 383 LATIN AMERICA: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 384 MIDDLE EAST: OTHER SUPPORTING EQUIPMENT MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 385 GCC COUNTRIES: OTHER SUPPORTING EQUIPMENT MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 386 CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 387 CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 388 NORTH AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 389 EUROPE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 390 ASIA PACIFIC: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 391 LATIN AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 392 MIDDLE EAST: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 393 GCC COUNTRIES: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 394 CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 395 CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 396 NORTH AMERICA: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 397 EUROPE: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 398 ASIA PACIFIC: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 399 LATIN AMERICA: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 400 MIDDLE EAST: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 401 GCC COUNTRIES: CELL CULTURE MARKET FOR MONOCLONAL ANTIBODY PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 402 CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 403 NORTH AMERICA: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 404 EUROPE: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 405 ASIA PACIFIC: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 406 LATIN AMERICA: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 407 MIDDLE EAST: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 408 GCC COUNTRIES: CELL CULTURE MARKET FOR VACCINE PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 409 CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 410 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 411 EUROPE: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 412 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 413 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 414 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 415 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER THERAPEUTIC PROTEIN PRODUCTION, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 416 CELL CULTURE MARKET FOR DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 417 NORTH AMERICA: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 418 EUROPE: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 419 ASIA PACIFIC: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 420 LATIN AMERICA: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 421 MIDDLE EAST: CELL CULTURE MARKET FOR DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 422 GCC COUNTRIES: CELL CULTURE MARKET FOR DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 423 CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 424 NORTH AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 425 EUROPE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 426 ASIA PACIFIC: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 427 LATIN AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 428 MIDDLE EAST: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 429 GCC COUNTRIES: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 430 CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 431 CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 432 NORTH AMERICA: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 433 EUROPE: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 434 ASIA PACIFIC: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 435 LATIN AMERICA: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 436 MIDDLE EAST: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 437 GCC COUNTRIES: CELL CULTURE MARKET FOR CELL & GENE THERAPY, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 438 CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 439 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 440 EUROPE: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 441 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 442 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 443 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 444 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER TISSUE ENGINEERING & REGENERATIVE MEDICINE APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 445 CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 446 NORTH AMERICA: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 447 EUROPE: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 448 ASIA PACIFIC: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 449 LATIN AMERICA: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 450 MIDDLE EAST: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 451 GCC COUNTRIES: CELL CULTURE MARKET FOR DRUG SCREENING & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 452 CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 453 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 454 EUROPE: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 455 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 456 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 457 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 458 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 459 CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 460 RECENT DEVELOPMENTS IN PHARMA & BIOTECH SECTOR
  • TABLE 461 CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 462 NORTH AMERICA: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 463 EUROPE: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 464 ASIA PACIFIC: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 465 LATIN AMERICA: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 466 MIDDLE EAST: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 467 GCC COUNTRIES: CELL CULTURE MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 468 CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 469 NORTH AMERICA: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 470 EUROPE: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 471 ASIA PACIFIC: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 472 LATIN AMERICA: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 473 MIDDLE EAST: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 474 GCC COUNTRIES: CELL CULTURE MARKET FOR HOSPITALS & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 475 CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 476 NORTH AMERICA: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 477 EUROPE: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 478 ASIA PACIFIC: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 479 LATIN AMERICA: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 480 MIDDLE EAST: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 481 GCC COUNTRIES: CELL CULTURE MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 482 CELL CULTURE MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 483 NORTH AMERICA: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 484 EUROPE: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 485 ASIA PACIFIC: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 486 LATIN AMERICA: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 487 MIDDLE EAST: CELL CULTURE MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 488 GCC COUNTRIES: CELL CULTURE MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 489 CELL CULTURE MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 490 NORTH AMERICA: CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 491 NORTH AMERICA: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 492 NORTH AMERICA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 493 NORTH AMERICA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 494 NORTH AMERICA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 495 NORTH AMERICA: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 496 NORTH AMERICA: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 497 NORTH AMERICA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 498 NORTH AMERICA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 499 NORTH AMERICA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 500 NORTH AMERICA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 501 NORTH AMERICA: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 502 NORTH AMERICA: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 503 NORTH AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 504 NORTH AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 505 NORTH AMERICA: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 506 INDICATIVE LIST OF CELL AND GENE THERAPIES APPROVED IN 2022
  • TABLE 507 US: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 508 US: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 509 US: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 510 US: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 511 US: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 512 US: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 513 US: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 514 US: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 515 US: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 516 US: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 517 US: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 518 US: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 519 US: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 520 US: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 521 US: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 522 CANADA: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 523 CANADA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 524 CANADA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 525 CANADA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 526 CANADA: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 527 CANADA: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 528 CANADA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 529 CANADA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 530 CANADA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 531 CANADA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 532 CANADA: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 533 CANADA: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 534 CANADA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 535 CANADA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 536 CANADA: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 537 EUROPE: CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 538 EUROPE: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 539 EUROPE: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 540 EUROPE: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 541 EUROPE: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 542 EUROPE: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 543 EUROPE: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 544 EUROPE: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 545 EUROPE: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 546 EUROPE: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 547 EUROPE: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 548 EUROPE: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 549 EUROPE: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 550 EUROPE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 551 EUROPE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 552 EUROPE: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 553 GERMANY: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 554 GERMANY: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 555 GERMANY: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 556 GERMANY: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 557 GERMANY: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 558 GERMANY: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 559 GERMANY: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 560 GERMANY: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 561 GERMANY: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 562 GERMANY: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 563 GERMANY: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 564 GERMANY: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 565 GERMANY: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 566 GERMANY: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 567 GERMANY: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 568 UK: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 569 UK: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 570 UK: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 571 UK: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 572 UK: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 573 UK: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 574 UK: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 575 UK: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 576 UK: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 577 UK: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 578 UK: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 579 UK: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 580 UK: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 581 UK: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 582 UK: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 583 FRANCE: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 584 FRANCE: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 585 FRANCE: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 586 FRANCE: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 587 FRANCE: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 588 FRANCE: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 589 FRANCE: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 590 FRANCE: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 591 FRANCE: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 592 FRANCE: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 593 FRANCE: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 594 FRANCE: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 595 FRANCE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 596 FRANCE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 597 FRANCE: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 598 ITALY: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 599 ITALY: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 600 ITALY: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 601 ITALY: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 602 ITALY: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 603 ITALY: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 604 ITALY: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 605 ITALY: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 606 ITALY: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 607 ITALY: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 608 ITALY: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 609 ITALY: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 610 ITALY: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 611 ITALY: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 612 ITALY: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 613 SPAIN: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 614 SPAIN: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 615 SPAIN: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 616 SPAIN: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 617 SPAIN: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 618 SPAIN: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 619 SPAIN: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 620 SPAIN: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 621 SPAIN: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 622 SPAIN: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 623 SPAIN: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 624 SPAIN: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 625 SPAIN: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 626 SPAIN: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 627 SPAIN: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 628 REST OF EUROPE: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 629 REST OF EUROPE: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 630 REST OF EUROPE: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 631 REST OF EUROPE: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 632 REST OF EUROPE: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 633 REST OF EUROPE: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 634 REST OF EUROPE: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 635 REST OF EUROPE: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 636 REST OF EUROPE: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 637 REST OF EUROPE: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 638 REST OF EUROPE: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 639 REST OF EUROPE: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 640 REST OF EUROPE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 641 REST OF EUROPE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 642 REST OF EUROPE: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 643 ASIA PACIFIC: CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 644 ASIA PACIFIC: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 645 ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 646 ASIA PACIFIC: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 647 ASIA PACIFIC: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 648 ASIA PACIFIC: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 649 ASIA PACIFIC: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 650 ASIA PACIFIC: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 651 ASIA PACIFIC: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 652 ASIA PACIFIC: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 653 ASIA PACIFIC: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 654 ASIA PACIFIC: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 655 ASIA PACIFIC: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 656 ASIA PACIFIC: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 657 ASIA PACIFIC: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 658 ASIA PACIFIC: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 659 CHINA: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 660 CHINA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 661 CHINA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 662 CHINA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 663 CHINA: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 664 CHINA: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 665 CHINA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 666 CHINA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 667 CHINA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 668 CHINA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 669 CHINA: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 670 CHINA: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 671 CHINA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 672 CHINA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 673 CHINA: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 674 JAPAN: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 675 JAPAN: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 676 JAPAN: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 677 JAPAN: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 678 JAPAN: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 679 JAPAN: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 680 JAPAN: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 681 JAPAN: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 682 JAPAN: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 683 JAPAN: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 684 JAPAN: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 685 JAPAN: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 686 JAPAN: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 687 JAPAN: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 688 JAPAN: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 689 INDIA: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 690 INDIA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 691 INDIA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 692 INDIA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 693 INDIA: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 694 INDIA: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 695 INDIA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 696 INDIA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 697 INDIA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 698 INDIA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 699 INDIA: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 700 INDIA: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 701 INDIA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 702 INDIA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 703 INDIA: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 704 SOUTH KOREA: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 705 SOUTH KOREA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 706 SOUTH KOREA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 707 SOUTH KOREA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 708 SOUTH KOREA: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 709 SOUTH KOREA: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 710 SOUTH KOREA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 711 SOUTH KOREA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 712 SOUTH KOREA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 713 SOUTH KOREA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 714 SOUTH KOREA: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 715 SOUTH KOREA: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 716 SOUTH KOREA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 717 SOUTH KOREA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 718 SOUTH KOREA: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 719 AUSTRALIA: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 720 AUSTRALIA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 721 AUSTRALIA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 722 AUSTRALIA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 723 AUSTRALIA: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 724 AUSTRALIA: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 725 AUSTRALIA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 726 AUSTRALIA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 727 AUSTRALIA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 728 AUSTRALIA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 729 AUSTRALIA: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 730 AUSTRALIA: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 731 AUSTRALIA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 732 AUSTRALIA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 733 AUSTRALIA: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 734 REST OF ASIA PACIFIC: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 735 REST OF ASIA PACIFIC: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 736 REST OF ASIA PACIFIC: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 737 REST OF ASIA PACIFIC: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 738 REST OF ASIA PACIFIC: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 739 REST OF ASIA PACIFIC: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 740 REST OF ASIA PACIFIC: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 741 REST OF ASIA PACIFIC: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 742 REST OF ASIA PACIFIC: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 743 REST OF ASIA PACIFIC: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 744 REST OF ASIA PACIFIC: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 745 REST OF ASIA PACIFIC: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 746 REST OF ASIA PACIFIC: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 747 REST OF ASIA PACIFIC: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 748 REST OF ASIA PACIFIC: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 749 LATIN AMERICA: CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 750 LATIN AMERICA: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 751 LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 752 LATIN AMERICA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 753 LATIN AMERICA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 754 LATIN AMERICA: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 755 LATIN AMERICA: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 756 LATIN AMERICA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 757 LATIN AMERICA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 758 LATIN AMERICA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 759 LATIN AMERICA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 760 LATIN AMERICA: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 761 LATIN AMERICA: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 762 LATIN AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 763 LATIN AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 764 LATIN AMERICA: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 765 BRAZIL: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 766 BRAZIL: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 767 BRAZIL: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 768 BRAZIL: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 769 BRAZIL: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 770 BRAZIL: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 771 BRAZIL: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 772 BRAZIL: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 773 BRAZIL: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 774 BRAZIL: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 775 BRAZIL: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 776 BRAZIL: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 777 BRAZIL: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 778 BRAZIL: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 779 BRAZIL: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 780 MEXICO: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 781 MEXICO: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 782 MEXICO: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 783 MEXICO: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 784 MEXICO: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 785 MEXICO: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 786 MEXICO: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 787 MEXICO: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 788 MEXICO: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 789 MEXICO: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 790 MEXICO: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 791 MEXICO: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 792 MEXICO: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 793 MEXICO: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 794 MEXICO: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 795 REST OF LATIN AMERICA: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 796 REST OF LATIN AMERICA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 797 REST OF LATIN AMERICA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 798 REST OF LATIN AMERICA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 799 REST OF LATIN AMERICA: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 800 REST OF LATIN AMERICA: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 801 REST OF LATIN AMERICA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 802 REST OF LATIN AMERICA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 803 REST OF LATIN AMERICA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 804 REST OF LATIN AMERICA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 805 REST OF LATIN AMERICA: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 806 REST OF LATIN AMERICA: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 807 REST OF LATIN AMERICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 808 REST OF LATIN AMERICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 809 REST OF LATIN AMERICA: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 810 MIDDLE EAST: CELL CULTURE MARKET, BY REGION, 2022–2029 (USD MILLION)
  • TABLE 811 MIDDLE EAST: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 812 MIDDLE EAST: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 813 MIDDLE EAST: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 814 MIDDLE EAST: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 815 MIDDLE EAST: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 816 MIDDLE EAST: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 817 MIDDLE EAST: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 818 MIDDLE EAST: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 819 MIDDLE EAST: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 820 MIDDLE EAST: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 821 MIDDLE EAST: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 822 MIDDLE EAST: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 823 MIDDLE EAST: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 824 MIDDLE EAST: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 825 MIDDLE EAST: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 826 GCC COUNTRIES: CELL CULTURE MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
  • TABLE 827 GCC COUNTRIES: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 828 GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 829 GCC COUNTRIES: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 830 GCC COUNTRIES: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 831 GCC COUNTRIES: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 832 GCC COUNTRIES: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 833 GCC COUNTRIES: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 834 GCC COUNTRIES: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 835 GCC COUNTRIES: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 836 GCC COUNTRIES: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 837 GCC COUNTRIES: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 838 GCC COUNTRIES: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 839 GCC COUNTRIES: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 840 GCC COUNTRIES: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 841 GCC COUNTRIES: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 842 SAUDI ARABIA: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 843 SAUDI ARABIA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 844 SAUDI ARABIA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 845 SAUDI ARABIA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 846 SAUDI ARABIA: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 847 SAUDI ARABIA: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 848 SAUDI ARABIA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 849 SAUDI ARABIA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 850 SAUDI ARABIA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 851 SAUDI ARABIA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 852 SAUDI ARABIA: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 853 SAUDI ARABIA: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 854 SAUDI ARABIA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 855 SAUDI ARABIA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 856 SAUDI ARABIA: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 857 UAE: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 858 UAE: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 859 UAE: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 860 UAE: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 861 UAE: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 862 UAE: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 863 UAE: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 864 UAE: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 865 UAE: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 866 UAE: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 867 UAE: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 868 UAE: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 869 UAE: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 870 UAE: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 871 UAE: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 872 REST OF GCC COUNTRIES: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 873 REST OF GCC COUNTRIES: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 874 REST OF GCC COUNTRIES: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 875 REST OF GCC COUNTRIES: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 876 REST OF GCC COUNTRIES: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 877 REST OF GCC COUNTRIES: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 878 REST OF GCC COUNTRIES: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 879 REST OF GCC COUNTRIES: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 880 REST OF GCC COUNTRIES: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 881 REST OF GCC COUNTRIES: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 882 REST OF GCC COUNTRIES: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 883 REST OF GCC COUNTRIES: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 884 REST OF GCC COUNTRIES: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 885 REST OF GCC COUNTRIES: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 886 REST OF GCC COUNTRIES: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 887 REST OF MIDDLE EAST: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 888 REST OF MIDDLE EAST: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 889 REST OF MIDDLE EAST: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 890 REST OF MIDDLE EAST: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 891 REST OF MIDDLE EAST: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 892 REST OF MIDDLE EAST: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 893 REST OF MIDDLE EAST: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 894 REST OF MIDDLE EAST: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 895 REST OF MIDDLE EAST: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 896 REST OF MIDDLE EAST: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 897 REST OF MIDDLE EAST: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 898 REST OF MIDDLE EAST: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 899 REST OF MIDDLE EAST: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 900 REST OF MIDDLE EAST: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 901 REST OF MIDDLE EAST: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 902 AFRICA: CELL CULTURE MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
  • TABLE 903 AFRICA: CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 904 AFRICA: SERA, MEDIA, AND REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 905 AFRICA: MEDIA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 906 AFRICA: REAGENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 907 AFRICA: SERA MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 908 AFRICA: VESSELS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 909 AFRICA: EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 910 AFRICA: BIOREACTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 911 AFRICA: STORAGE EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 912 AFRICA: OTHER EQUIPMENT MARKET, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 913 AFRICA: CELL CULTURE MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
  • TABLE 914 AFRICA: CELL CULTURE MARKET FOR BIOPHARMACEUTICAL PRODUCTION, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 915 AFRICA: CELL CULTURE MARKET FOR TISSUE ENGINEERING & REGENERATIVE MEDICINE, BY TYPE, 2022–2029 (USD MILLION)
  • TABLE 916 AFRICA: CELL CULTURE MARKET, BY END USER, 2022–2029 (USD MILLION)
  • TABLE 917 STRATEGIES ADOPTED BY KEY PLAYERS IN CELL CULTURE MARKET, 2022−2024
  • TABLE 918 CELL CULTURE MARKET: DEGREE OF COMPETITION
  • TABLE 919 CELL CULTURE MARKET: PRODUCT FOOTPRINT
  • TABLE 920 CELL CULTURE MARKET: APPLICATION FOOTPRINT
  • TABLE 921 CELL CULTURE MARKET: END-USER FOOTPRINT
  • TABLE 922 CELL CULTURE MARKET: REGIONAL FOOTPRINT
  • TABLE 923 CELL CULTURE MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
  • TABLE 924 CELL CULTURE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
  • TABLE 925 CELL CULTURE MARKET: PRODUCT LAUNCHES, JANUARY 2021–FEBRUARY 2024
  • TABLE 926 CELL CULTURE MARKET: DEALS, JANUARY 2021–FEBRUARY 2024
  • TABLE 927 CELL CULTURE MARKET: EXPANSIONS, JANUARY 2021–FEBRUARY 2024
  • TABLE 928 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
  • TABLE 929 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
  • TABLE 930 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES
  • TABLE 931 THERMO FISHER SCIENTIFIC INC.: DEALS
  • TABLE 932 THERMO FISHER SCIENTIFIC INC.: EXPANSIONS
  • TABLE 933 DANAHER CORPORATION: BUSINESS OVERVIEW
  • TABLE 934 DANAHER CORPORATION: PRODUCTS OFFERED
  • TABLE 935 DANAHER CORPORATION: PRODUCT LAUNCHES
  • TABLE 936 DANAHER CORPORATION: DEALS
  • TABLE 937 DANAHER CORPORATION: EXPANSIONS
  • TABLE 938 DANAHER CORPORATION: OTHER DEVELOPMENTS
  • TABLE 939 MERCK KGAA: BUSINESS OVERVIEW
  • TABLE 940 MERCK KGAA: PRODUCTS OFFERED
  • TABLE 941 MERCK KGAA: PRODUCT LAUNCHES
  • TABLE 942 MERCK KGAA: DEALS
  • TABLE 943 MERCK KGAA: EXPANSIONS
  • TABLE 944 SARTORIUS AG: BUSINESS OVERVIEW
  • TABLE 945 SARTORIUS AG: PRODUCTS OFFERED
  • TABLE 946 SARTORIUS AG: PRODUCT LAUNCHES
  • TABLE 947 SARTORIUS AG: DEALS
  • TABLE 948 SARTORIUS AG: EXPANSIONS
  • TABLE 949 CORNING INCORPORATED: BUSINESS OVERVIEW
  • TABLE 950 CORNING INCORPORATED: PRODUCTS OFFERED
  • TABLE 951 CORNING INCORPORATED: PRODUCT LAUNCHES
  • TABLE 952 CORNING INCORPORATED: DEALS
  • TABLE 953 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW
  • TABLE 954 FUJIFILM HOLDINGS CORPORATION: PRODUCTS OFFERED
  • TABLE 955 FUJIFILM HOLDINGS CORPORATION: PRODUCT LAUNCHES
  • TABLE 956 FUJIFILM HOLDINGS CORPORATION: DEALS
  • TABLE 957 FUJIFILM HOLDINGS CORPORATION: EXPANSIONS
  • TABLE 958 BD: BUSINESS OVERVIEW
  • TABLE 959 BD: PRODUCTS OFFERED
  • TABLE 960 BD: PRODUCT LAUNCHES
  • TABLE 961 BD: DEALS
  • TABLE 962 EPPENDORF SE: BUSINESS OVERVIEW
  • TABLE 963 EPPENDORF SE: PRODUCTS OFFERED
  • TABLE 964 EPPENDORF SE: PRODUCT LAUNCHES
  • TABLE 965 EPPENDORF SE: DEALS
  • TABLE 966 EPPENDORF SE: EXPANSIONS
  • TABLE 967 LONZA: BUSINESS OVERVIEW
  • TABLE 968 LONZA: PRODUCTS OFFERED
  • TABLE 969 LONZA: PRODUCT LAUNCHES
  • TABLE 970 LONZA: DEALS
  • TABLE 971 GETINGE AB: BUSINESS OVERVIEW
  • TABLE 972 GETINGE AB: PRODUCTS OFFERED
  • TABLE 973 GETINGE AB: PRODUCT LAUNCHES
  • TABLE 974 GETINGE AB: DEALS
  • TABLE 975 GETINGE AB: EXPANSIONS
  • TABLE 976 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
  • TABLE 977 AGILENT TECHNOLOGIES, INC.: PRODUCTS OFFERED
  • TABLE 978 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES
  • TABLE 979 AGILENT TECHNOLOGIES, INC.: DEALS
  • TABLE 980 HIMEDIA LABORATORIES: BUSINESS OVERVIEW
  • TABLE 981 HIMEDIA LABORATORIES: PRODUCTS OFFERED
  • TABLE 982 BIO-TECHNE: COMPANY OVERVIEW
  • TABLE 983 BIO-TECHNE: PRODUCTS OFFERED
  • TABLE 984 BIO-TECHNE: PRODUCT LAUNCHES
  • TABLE 985 BIO-TECHNE: DEALS
  • TABLE 986 MILTENYI BIOTEC: BUSINESS OVERVIEW
  • TABLE 987 STEMCELL TECHNOLOGIES: BUSINESS OVERVIEW
  • TABLE 988 SOLIDA BIOTECH GMBH: BUSINESS OVERVIEW
  • TABLE 989 CAISSON LABS INC.: BUSINESS OVERVIEW
  • TABLE 990 PROMOCELL GMBH: BUSINESS OVERVIEW
  • TABLE 991 INVIVOGEN: BUSINESS OVERVIEW
  • TABLE 992 PAN-BIOTECH: BUSINESS OVERVIEW
  • TABLE 993 CELLEXUS: BUSINESS OVERVIEW
  • TABLE 994 MEISSNER FILTRATION PRODUCTS, INC.: BUSINESS OVERVIEW
  • TABLE 995 ADOLF KÜHNER AG: BUSINESS OVERVIEW
  • TABLE 996 ADVANCION CORPORATION: BUSINESS OVERVIEW
  • TABLE 997 BIOSPHERIX, LTD.: BUSINESS OVERVIEW
LIST OF FIGURES
 
  • FIGURE 1 RESEARCH DESIGN
  • FIGURE 2 BREAKDOWN OF PRIMARIES: CELL CULTURE MARKET
  • FIGURE 3 CELL CULTURE MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023
  • FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023
  • FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS (2023)
  • FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES
  • FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 8 CELL CULTURE MARKET (SUPPLY-SIDE): CAGR PROJECTIONS
  • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • FIGURE 10 CELL CULTURE MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION)
  • FIGURE 11 CELL CULTURE MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 12 CELL CULTURE MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
  • FIGURE 13 GEOGRAPHICAL SNAPSHOT OF CELL CULTURE MARKET
  • FIGURE 14 INCREASING APPROVALS AND LAUNCHES OF BIOLOGICAL DRUGS TO SUPPORT MARKET GROWTH
  • FIGURE 15 CONSUMABLES ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN MARKET IN 2023
  • FIGURE 16 BIOPHARMACEUTICAL PRODUCTION SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • FIGURE 17 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT DOMINATED END-USER MARKET IN 2023
  • FIGURE 18 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD
  • FIGURE 19 CELL CULTURE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 20 NUMBER OF ANTIBODY THERAPEUTICS GRANTED FIRST APPROVAL IN US/EU (2012−2023)
  • FIGURE 21 NUMBER OF BIOSIMILARS APPROVED AND LAUNCHED (2015−2024)
  • FIGURE 22 CLINICAL TRIALS OVERVIEW OF TISSUE-ENGINEERED PRODUCTS (2019–2023)
  • FIGURE 23 GLOBAL HIV EPIDEMIC, 2022
  • FIGURE 24 RSV VACCINE AND MAB SNAPSHOT (AS OF JANUARY 2024)
  • FIGURE 25 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
  • FIGURE 26 TOTAL NUMBER OF PATENTS GRANTED, 2014–2024
  • FIGURE 27 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014–2024
  • FIGURE 28 VALUE CHAIN ANALYSIS: RAW MATERIAL AND MANUFACTURING PHASE CONTRIBUTE MAXIMUM VALUE
  • FIGURE 29 CELL CULTURE MARKET: SUPPLY CHAIN ANALYSIS
  • FIGURE 30 CELL CULTURE MARKET: ECOSYSTEM ANALYSIS
  • FIGURE 31 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF CELL CULTURE PRODUCTS
  • FIGURE 32 KEY BUYING CRITERIA FOR END USERS
  • FIGURE 33 NORTH AMERICA: CELL CULTURE MARKET SNAPSHOT
  • FIGURE 34 ASIA PACIFIC: CELL CULTURE MARKET SNAPSHOT
  • FIGURE 35 REVENUE ANALYSIS OF KEY PLAYERS IN CELL CULTURE MARKET, 2019–2023 (USD BILLION)
  • FIGURE 36 CELL CULTURE MARKET SHARE ANALYSIS, BY KEY PLAYER (2023)
  • FIGURE 37 BRAND/PRODUCT COMPARATIVE ANALYSIS, BY PRODUCT
  • FIGURE 38 CELL CULTURE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 39 CELL CULTURE MARKET: COMPANY FOOTPRINT
  • FIGURE 40 CELL CULTURE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
  • FIGURE 41 EV/EBITDA OF KEY VENDORS
  • FIGURE 42 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
  • FIGURE 43 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • FIGURE 44 DANAHER CORPORATION: COMPANY SNAPSHOT
  • FIGURE 45 MERCK KGAA: COMPANY SNAPSHOT
  • FIGURE 46 SARTORIUS AG: COMPANY SNAPSHOT
  • FIGURE 47 CORNING INCORPORATED: COMPANY SNAPSHOT
  • FIGURE 48 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 49 BD: COMPANY SNAPSHOT
  • FIGURE 50 EPPENDORF SE: COMPANY SNAPSHOT
  • FIGURE 51 LONZA: COMPANY SNAPSHOT
  • FIGURE 52 GETINGE AB: COMPANY SNAPSHOT
  • FIGURE 53 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT
  • FIGURE 54 BIO-TECHNE: COMPANY SNAPSHOT

This research study involved the extensive use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global cell culture market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and assess the growth prospects of the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the cell culture market. The secondary sources used for this study include World Health Organization (WHO), Food and Drug Administration, American Society for Cell Biology (ASCB), National Institutes of Health (NIH), International Society for Cell & Gene Therapy (ISCT),  American Society for Gene and Cell Therapy (ASGCT), Centers of Disease Control and Prevention (CDC), International Serum Industry Association (ISIA), Pharmaceutical Research and Manufacturers of America (PhRMA), International Society for Vaccines (ISV), International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), the Society for In Vitro Biology (SIVB), Japan Agency for Medical Research and Development, European Federation of Pharmaceutical Industries and Associations (EFPIA), American Type Culture Collection (ATCC), and the Alliance for Regenerative Medicine (ARM); corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; trade, business, professional associations and among others. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

Extensive primary research was conducted after acquiring basic knowledge about the global cell culture market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as pharmaceutical and biopharmaceutical companies, hospitals & diagnostic laboratories, research & academic institutes, CROs, and CMOs, and experts from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. These interviews were conducted across six major regions, including the North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

The following is a breakdown of the primary respondents:

Cell Culture  Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the cell culture market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

Bottom-up Approach

  • The key players in the industry and market have been identified through extensive secondary research
  • The revenues generated from the cell culture business of leading players have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Cell Culture  Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Top-down Approach

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

Cell Culture  Market Size, and Share

Data Triangulation

After arriving at the market size  from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Market Definition

Cell culture refers to removing cells from an animal or plant and their subsequent growth in an artificial environment under controlled conditions. It is a process of growing cells outside their natural environment, typically in a laboratory setting. This technique allows researchers to study cells in a controlled environment, providing insights into their behavior, growth, metabolism, and response to various stimuli.

Stakeholders

  • Cell Culture Equipment and Reagents Manufacturers
  • Analytical and Life Science Instrumentation Companies
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Life Science Companies
  • Venture Capitalists and Investors
  • Government Organizations
  • Private Research Firms
  • Contract Research Organizations (CROs)
  • Contract Development and Manufacturing Organizations (CDMOs)
  • Hospitals and Diagnostic Laboratories
  • Cell Banks

Report Objectives

  • To define, describe, and forecast the global cell culture market based on the product, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
  • To strategically analyze micro-markets with respect to individual growth trends, future prospects, and contributions to the overall cell culture market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, Asia Pacific, Latin America, Middle East, and Africa
  • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as acquisitions, product launches, expansions, and R&D activities in the cell culture market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Portfolio Assessment

  • Product Matrix, which gives a detailed comparison of the product portfolios of the top three companies.

Company Information

  • Detailed analysis and profiling of additional market players (up to three).

Geographical Analysis

  • A further breakdown of the Rest of Asia Pacific cell culture market into countries
  • A further breakdown of the Rest of European cell culture market into countries
  • A further breakdown of the Rest of Latin American cell culture market into countries
  • A further breakdown of the Rest of Middle East cell culture market into countries

Previous Versions of this Report

Cell Culture Market by Product (Consumables (Media, Serum, Reagent, Vessels), Equipment (Bioreactor, Centrifuge, Incubator)), Application (Vaccines, mAbs, Diagnostics, Tissue Engineering), End User (Pharma, Biotech, Hospital) & Region - Global Forecasts to 2026

Report Code BT 2561
Published in Mar, 2023, By MarketsandMarkets™

Cell Culture Market by Product (Consumables (Media, Serum, Reagent, Vessels), Equipment (Bioreactor, Centrifuge, Incubator)), Application (Vaccines, mAbs, Diagnostics, Tissue Engineering), End User (Pharma, Biotech, Hospital) - Global Forecast to 2026

Report Code BT 2561
Published in Feb, 2022, By MarketsandMarkets™

Cell Culture Market by Product (Consumables (Media, Serum, Vessels), Equipment (Bioreactor, Centrifuge, Incubator, Autoclave)), Application (Therapeutic Proteins, Vaccines, Diagnostics, Stem cells), End User (Pharma, Biotech) - Global Forecast to 2025

Report Code BT 2561
Published in Nov, 2020, By MarketsandMarkets™

Cell Culture Market by Product (Consumables (Media, FBS), Equipment (Bioreactor, Centrifuge, Incubator, Microscope, Autoclave)), Application (Stem Cell, Vaccines, Therapeutic proteins), End User (Pharma, Research Institutes) - Global Forecast to 2024

Report Code BT 2561
Published in Jul, 2019, By MarketsandMarkets™

Cell Culture Market by Consumables (Serum free media, FBS, ABS), Equipment {Bioreactor, Supporting Equipment (Centrifuge, Filtration System)}, Application (Biopharmaceutical, Cancer Research), End Users (Pharma, Research) - Global Forecast to 2023

Report Code BT 2561
Published in Apr, 2018, By MarketsandMarkets™

Cell Culture Market by Equipment (Bioreactor, Culture Vessels (Multiwell Plates, Petri Dish)), Consumables (FBS, ABS, Media, Reagents), Application (Therapeutics, Stem Cell), End Users (Pharmaceutical and Biotechnology, Research) - Forecast to 2020

Report Code BT 2561
Published in Feb, 2016, By MarketsandMarkets™

Cell Culture Market by Equipment (Bioreactor, Incubator, Centrifuge), by Reagent (Media, Sera, Growth Factors, Serum Free Media), by Application (Cancer Research, Gene Therapy, Drug Development, Vaccine Production, Toxicity Testing) - Global Forecast to 2018

Report Code BT 2561
Published in Jul, 2014, By MarketsandMarkets™
"Our USP is "providing game-changing business opportunities reports with free customization" - so please feel free to provide us with your specific areas of interest / business challenges in much greater detail !!"

We appreciate your interest in this report. Once you fill out the form, you'll be immediately directed to an exclusive solution tailored to your needs. This high-value offering can help boost your revenue by 30% - a must-see opportunity for anyone looking to maximize growth.


By clicking the "Submit" button, you are agreeing to the Terms of Use and Privacy Policy.

Custom Market Research Services

We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements

Get 10% Free Customisation

Growth opportunities and latent adjacency in Cell Culture Market

Alan

Mar, 2022

Which market size estimation methodologies are adopted to study the Global Cell Culture Market?.

Juan

Mar, 2022

How much percent share, does each segment holds, of the Global Cell Culture Market?.

Wayne

Mar, 2022

What are the growth opportunities in the Global Cell Culture Market across different geographies?.

DMCA.com Protection Status